Testing lab markers that may predict chemotherapy benefit
Part of Cancer, Digestive system clinical trials.
This pilot study looks at stomach (gastric) and upper stomach/cardia cancer to find lab “markers” that could predict whether chemotherapy before and after surgery will work better. If you qualify, your tumor or blood samples may be tested to understand who benefits most from treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stomach cancer (gastric adenocarcinoma) or cardia cancer
- You are over 18 years old
- Your overall health score is 3 or less (WHO performance status)
- You can and do sign informed consent
- You are not currently being treated with chemotherapy for another cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This trial collects and studies tumor and lymph node samples from people with gastric cancer who have had chemotherapy and surgery. The goal is to understand how cancer responds to treatment and to improve future care.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
This study uses special blood tests to detect cancer DNA and help doctors decide the best treatment plan for gastric cancer. The goal is to improve outcomes by personalizing therapy based on how your cancer responds.
This research study analyzes tumor tissue samples to understand why some patients respond better to chemotherapy after gastric cancer surgery. By studying how genes are processed in cancer cells, researchers hope to predict which patients will benefit most from treatment.
This trial uses a combination of CT scans, ultrasound, and blood tests to predict how well chemotherapy will work for people with locally advanced gastric cancer. The goal is to personalize treatment by identifying who will respond best to neoadjuvant chemotherapy.
Hear when a new Gastric and Cardia Adenocarcinomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.